April 23, 2002 Protecting Human Subjects in Research: Are Current Safeguards Adequate?AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Read More Protecting Human Subjects in Research: Are Current Safeguards Adequate?
January 28, 2002 Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children"minimal risk" "minor increment of minimal risk" and "disorder or condition" January 28, 2001 A cornerstone of Read More Linguistic Tinkering with Regulatory Terminology Increases Risk of Harm for Children
October 1, 2001 AHRP Amicus Brief – Kennedy Krieger InstituteIN THE COURT OF APPEALS OF MARYLAND No. 128 September Term, 2000 ERICKA GRIMES, Appellant v. KENNEDY Read More AHRP Amicus Brief – Kennedy Krieger Institute
August 6, 2001 FDA: Regulatory Protections for ChildrenComments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for Read More FDA: Regulatory Protections for Children
July 25, 2001 Dissenting Opinion: Against Waiving Parental Permission for ResearchTo: Mary Faith Marshall, Ph.D, Chairperson, National Human Research Protections Advisory Committee Department of Health and Human Read More Dissenting Opinion: Against Waiving Parental Permission for Research
April 5, 2001 Testimony Re: Research Involving ChildrenFederal policy, until now, has been to protect children from non-essential, invasive, painful medical experiments that are Read More Testimony Re: Research Involving Children
December 20, 2000 How a New Policy Led to Seven Deadly Drugs“The FDA used to serve a purpose….A doctor could feel sure that a drug he was prescribing Read More How a New Policy Led to Seven Deadly Drugs